Intravitreales Bevacizumab vs. Verteporfin und intravitreales Triamcinolon Acetonid bei Patienten mit neovaskulärer AMD

Author: Hahn R.   Sacu S.   Michels S.   Varga A.   Weigert G.   Geitzenauer W.   Vécsei-Marlovits P.   Schmidt-Erfurth U.  

Publisher: Springer Publishing Company

ISSN: 0941-293X

Source: Der Ophthalmologe, Vol.104, Iss.7, 2007-07, pp. : 588-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next